A pharmaceutical product including a container constructed from a polymeric material containing one or more of a terephthalate ester group, an amorphous nylon, fluorinated ethylene-propylene, and combinations thereof. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
